2010 versus the 2000 consensus criteria in patients with normalised insulin‐like growth factor 1 after transsphenoidal surgery has high predictive values for long‐term recurrence‐free survival in acromegaly - Shen - 2021
Por um escritor misterioso
Descrição
Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future in: Endocrine-Related Cancer Volume 23 Issue 12 (2016)
Acromegaly - ScienceDirect
Frontiers Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy
Acromegaly - ScienceDirect
Assessment of sFRP4 as a bio-marker for predicting aggressiveness and recurrence of growth hormone-secreting pituitary adenomas
(PDF) How are growth hormone and insulin-like growth factor-1 reported as markers for drug effectiveness in clinical acromegaly research? A comprehensive methodologic review
pasireotide
Cells, Free Full-Text
Recurrence after pituitary surgery in adult Cushing's disease: a systematic review on diagnosis and treatment
Characteristics of Gut Microbiota in Patients with GH-Secreting Pituitary Adenoma
Frontiers Interpreting growth hormone and IGF-I results using modern assays and reference ranges for the monitoring of treatment effectiveness in acromegaly
de
por adulto (o preço varia de acordo com o tamanho do grupo)
